| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |